Integrating heterogeneous genomic and clinical modalities for joint cancer subtype classification and survival prediction remains a key challenge in precision oncology. Existing approaches suffer from three limitations:
- They treat each modality as a monolithic feature vector, precluding fine-grained token-level interactions across modalities;
- Cross-modal fusion is typically performed through linear weighting or late averaging rather than structured token exchange;
- Survival and classification objectives are optimized independently, missing a joint regularization signal.
These limitations hinder the performance and effectiveness of models, necessitating new approaches to overcome these challenges.
Blogger's Review: The novel cross-modal transformer proposed in this paper offers fresh insights into addressing existing issues in cancer subtype classification and survival prediction, particularly through fine-grained token interactions and joint optimization, significantly enhancing model capability and accuracy.